NeonMind Appoints Trevor Millar as Chief Psychedelic Officer
Vancouver, British Columbia--(Newsfile Corp. - January 7, 2021) - NeonMind Biosciences Inc. (CSE: NEON) ("NeonMind"), a company conducting research into the potentially therapeutic uses of compounds found in psychedelic mushrooms and commercializing medicinal mushroom products, is pleased to announce that it has appointed Trevor Millar as Chief Psychedelic Officer of NeonMind as of January 6, 2021. NeonMind Appoints Trevor Millar as Chief Psy
2021-01-07 6:30 AM EST
NeonMind Commences Trading Under CSE Ticker Symbol "NEON"
Vancouver, British Columbia--(Newsfile Corp. - January 4, 2021) - NeonMind Biosciences Inc. (CSE: NEON) ("NeonMind") is pleased to announce that its common shares have today commenced trading on the Canadian Securities Exchange (the "Exchange") under the ticker symbol "NEON". More information on NeonMind can be found at www.neonmindbiosciences.com.
2021-01-04 6:00 AM EST
NeonMind Announces Closing of Oversubscribed Initial Public Offering and Exercise in Full of the Agent's Over-Allotment Option
Vancouver, British Columbia--(Newsfile Corp. - December 30, 2020) - NeonMind Biosciences Inc. (CSE: NEON) ("NeonMind"), is pleased to announce that it has successfully completed the maximum offering for its initial public offering (the "IPO") of 46,000,000 units of NeonMind (the "Units") at a price to the public of $0.10 per Unit, including 6,000,000 in additional Units pursuant to the exercise in full of the over-allotment option. The gross proceeds from the IPO, before deducting agent fees...
2020-12-30 6:06 PM EST